These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 25691688)

  • 21. Metabolome analysis for investigating host-gut microbiota interactions.
    Chen MX; Wang SY; Kuo CH; Tsai IL
    J Formos Med Assoc; 2019 Mar; 118 Suppl 1():S10-S22. PubMed ID: 30269936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The relationship between gut microbiota and diet and nutrition related diseases].
    Wang MQ; Li Y; Sun CH
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Feb; 52(2):195-200. PubMed ID: 29429278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk.
    Koopen AM; Groen AK; Nieuwdorp M
    Curr Opin Lipidol; 2016 Dec; 27(6):615-622. PubMed ID: 27676197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of NMR-based metabolomics to the study of gut microbiota in obesity.
    Calvani R; Brasili E; Praticò G; Sciubba F; Roselli M; Finamore A; Marini F; Marzetti E; Miccheli A
    J Clin Gastroenterol; 2014; 48 Suppl 1():S5-7. PubMed ID: 25291128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implication of gut microbiota metabolites in cardiovascular and metabolic diseases.
    Brial F; Le Lay A; Dumas ME; Gauguier D
    Cell Mol Life Sci; 2018 Nov; 75(21):3977-3990. PubMed ID: 30101405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the Gut Microbiome in Diabetes and Cardiovascular Diseases Including Restoration and Targeting Approaches- A Review.
    Alka Ahuja ; Saraswathy Mp ; Nandakumar S ; Prakash F A; Kn G; Um D
    Drug Metab Bioanal Lett; 2022; 15(3):133-149. PubMed ID: 36508273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A review of metabolic potential of human gut microbiome in human nutrition.
    Yadav M; Verma MK; Chauhan NS
    Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut Microbiota in Vascular Disease: Therapeutic Target?
    Anbazhagan AN; Priyamvada S; Priyadarshini M
    Curr Vasc Pharmacol; 2017; 15(4):291-295. PubMed ID: 28056754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endocrine organs of cardiovascular diseases: Gut microbiota.
    Jia Q; Xie Y; Lu C; Zhang A; Lu Y; Lv S; Zhang J
    J Cell Mol Med; 2019 Apr; 23(4):2314-2323. PubMed ID: 30688023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe.
    Lamichhane S; Sen P; Dickens AM; Orešič M; Bertram HC
    Methods; 2018 Oct; 149():3-12. PubMed ID: 29715508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Metabolic Role and Therapeutic Potential of the Microbiome.
    Olofsson LE; Bäckhed F
    Endocr Rev; 2022 Sep; 43(5):907-926. PubMed ID: 35094076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Administration of Porphyromonas gingivalis Alters the Gut Microbiome and Serum Metabolome.
    Kato T; Yamazaki K; Nakajima M; Date Y; Kikuchi J; Hase K; Ohno H; Yamazaki K
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30333180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of the microbiome in energy regulation and metabolism.
    Nieuwdorp M; Gilijamse PW; Pai N; Kaplan LM
    Gastroenterology; 2014 May; 146(6):1525-33. PubMed ID: 24560870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gut microbiome and cardiometabolic risk.
    Kappel BA; Federici M
    Rev Endocr Metab Disord; 2019 Dec; 20(4):399-406. PubMed ID: 31836950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health.
    Ha CW; Lam YY; Holmes AJ
    World J Gastroenterol; 2014 Nov; 20(44):16498-517. PubMed ID: 25469018
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk.
    Kurilshikov A; van den Munckhof ICL; Chen L; Bonder MJ; Schraa K; Rutten JHW; Riksen NP; de Graaf J; Oosting M; Sanna S; Joosten LAB; van der Graaf M; Brand T; Koonen DPY; van Faassen M; ; Slagboom PE; Xavier RJ; Kuipers F; Hofker MH; Wijmenga C; Netea MG; Zhernakova A; Fu J
    Circ Res; 2019 Jun; 124(12):1808-1820. PubMed ID: 30971183
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional interactions between the gut microbiota and host metabolism.
    Tremaroli V; Bäckhed F
    Nature; 2012 Sep; 489(7415):242-9. PubMed ID: 22972297
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolomics and Lipidomics Approaches in the Science of Probiotics: A Review.
    Chung HJ; Sim JH; Min TS; Choi HK
    J Med Food; 2018 Nov; 21(11):1086-1095. PubMed ID: 30004273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-digestible food ingredients, colonic microbiota and the impact on gut health and immunity: a role for metabolomics.
    Jacobs DM; Gaudier E; van Duynhoven J; Vaughan EE
    Curr Drug Metab; 2009 Jan; 10(1):41-54. PubMed ID: 19149512
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis.
    Li RJ; Jie ZY; Feng Q; Fang RL; Li F; Gao Y; Xia HH; Zhong HZ; Tong B; Madsen L; Zhang JH; Liu CL; Xu ZG; Wang J; Yang HM; Xu X; Hou Y; Brix S; Kristiansen K; Yu XL; Jia HJ; He KL
    Front Cell Infect Microbiol; 2021; 11():708088. PubMed ID: 34692558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.